Order results by:
| Issue | Title | |
| Vol 12, No 2 (2019) | Health technology assessment and reimbursement of pharmaceuticals in Italy | Abstract similar documents |
| F. V. Gorkavenko, V. V. Omelyanovskiy, T. P. Bezdenezhnykh, G. R. Khachatryan | ||
| "... ) is the national health technology assessment (HTA) authority in charge of the reimbursement and formulary-listing ..." | ||
| Vol 12, No 2 (2019) | Organizational structure and funding of health technology assessment agencies around the world | Abstract similar documents |
| G. R. Khachatryan, V. V. Omelyanovskiy, L. S. Melnikova, S. S. Ratushnyak | ||
| "... : «organizational structure of HTA agency», «funding of HTA agency», «pharmaceutical», «reimbursement», «healthcare ..." | ||
| Vol 6, No 2 (2013) | HTA CORE MODEL | Abstract similar documents |
| R. I. Yagudina, T. Yu. Nor, A. D. Sevostyanov | ||
| "... and reporting methods. The HTA Core Model aim is to create a single database on health technologies, which might ..." | ||
| Vol 11, No 3 (2018) | The concept of multi-criteria analysis of decision-making in the current system of health technology assessment in Russia | Abstract similar documents |
| V. V. Omelyanovsky, V. K. Fedyaeva, N. Z. Musina | ||
| "... the principles of health technologies assessment (HTA) and the reimbursement strategies in Russia have been put ..." | ||
| Vol 12, No 4 (2019) | The health technology assessment system in Australia | Abstract similar documents |
| V. V. Omelyanovskiy, E. S. Saybel, T. P. Bezdenezhnykh, G. R. Khachatryan | ||
| "... for the health technology assessment (HTA) and decides which technology is eligible for reimbursement ..." | ||
| Vol 11, No 4 (2018) | International experience in determining the cost-effectiveness thresholds | Abstract similar documents |
| T. P. Bezdenezhnykh, N. Z. Musina, V. K. Fedyaeva, T. S. Tepcova, V. A. Lemeshko, V. V. Omelyanovsky | ||
| "... reimbursement. The present review demonstrates that just a few countries (englandandWales,Thailand,Poland,USA ..." | ||
| Vol 9, No 3 (2016) | EARLY HEALTH TECHNOLOGIES ASSESSMENT — NEW APPROACH TO IMPROVING THE EFFICIENCY OF THE MEDICAL TECHNOLOGY DEVELOPMENT PROCESS | Abstract similar documents |
| N. Z. Musina, V. V. Omelyanovskiy, A. V. Krasheninnikova | ||
| "... Early health technologies assessment (HTA) is a form of HTA, which takes place at early stages ..." | ||
| Vol 13, No 2 (2020) | Affordability of in vivo gene therapy. Problems and potential solutions | Abstract similar documents |
| V. V. Omelyanovskiy, N. Z. Musina, V. A. Lemeshko, A. A. Antonov, F. V. Gorkavenko | ||
| "... not reveal general methodological peculiarities. The analysis of the approaches to the reimbursement ..." | ||
| Vol 11, No 2 (2018) | Introduction of medical products into healthcare practice and costs reimbursement: European experience | Abstract similar documents |
| V. V. Omelyanovsky, S. S. Otstavnov, N. Z. Musina, V. S. Dombrovskii | ||
| "... здравоохранения в ряде стран Европейского Союза. Проведенный анализ позволил выявить и общие черты, к примеру ..." | ||
| Vol 8, No 1 (2015) | PAYMENT OF NEW EXPENSIVE TECHNOLOGIES IN HEALTH CARE ON THE BASIS OF RISKS -SHARING AGREEMENTS: POSSIBILITIES OF APPLICATION IN THE RUSSIAN FEDERATION | Abstract similar documents |
| L. S. Melnikova | ||
| "... are used in foreign countries at reimbursement of costs for public drug supply. The author estimates ..." | ||
| Vol 11, No 2 (2018) | Pharmacoeconomic analysis of treatment with nilotinib as the second line therapy in patients with chronic myeloid leukemia | Abstract similar documents |
| N. A. Avxentyev, M. Yu. Frolov, A. S. Makarov | ||
| "... are registered in second-line, however only dasatinib is included in the government drug reimbursement program ..." | ||
| Vol 11, No 3 (2018) | What is the role of antineoplastic drug safety in reimbursement decision making? | Abstract similar documents |
| A. S. Kolbin, A. A. Kurylev | ||
| "... to reimbursement in Russia has grown from 15% to 28%. This group of drugs is characterized by severe adverse events ..." | ||
| Vol 7, No 4 (2014) | ROAD MAP FOR DEVELOPMENT OF PRICE REGULATION SYSTEM AND SYSTEM OF DRUG SUPPLY AT THE EXPENSE OF RUSSIAN FEDERATION HEALTHCARE SYSTEM FUNDS | Abstract similar documents |
| M. V. Sura, K. V. Gerasimova, V. V. Omelyanovskiy, M. V. Avksentieva | ||
| "... drug supply (comprehensive drug reimbursement system) and reference pricing. The analysis of prices ..." | ||
| Vol 9, No 1 (2016) | MATHEMATICAL MODEL OF REIMBURSEMENT DECISION MAKING IN RUSSIA. RESULTS OF VIM LIST FOR 2016 | Abstract similar documents |
| A. S. Kolbin, A. V. Prasolov, E. A. Maksimkina, Yu. E. Balykina, Z. M. Golant, Yu. S. Polushin, A. A. Kurylev, I. A. Vilyum | ||
| "... inclusion and exclusion into the reimbursement lists in Russian Federation. The liner mathematical model ..." | ||
| Vol 7, No 2 (2014) | PARAMETERS OF HEALTH CARE SYSTEMS | Abstract similar documents |
| V. V. Omelyanovskiy, I. V. Maksimova, A. P. Tatarinov | ||
| "... в любой стране выбор оптимальной модели здравоохранения имеет принципиальное значение для ..." | ||
| Vol 11, No 2 (2018) | Regional adaptation of the federal model of reimbursement for medical assistance based on clinical statistical groups: hospitalization of patients in need of genetically enginered biological preparations | Abstract similar documents |
| M. V. Sura, T. N. Ignatova, N. S. Rudneva, Yu. N. Sukhanova, N. G. Ulyanova, A. S. Khudyaev, V. A. Shelyakin, D. V. Scherbakov | ||
| "... ) in 2018 provides for the reimbursement for hospital stay expenses by the compulsory medical insurance fund ..." | ||
| Vol 7, No 4 (2014) | IS RUSSIA READY FOR THE INTRODUCTION OF THE NATIONAL REFERENCE PRICING SYSTEM? | Abstract similar documents |
| V. V. Omelyanovskiy | ||
| "... reimbursement) shows a substantial variety and presence of national peculiarities; however the majority ..." | ||
| Vol 9, No 4 (2016) | FACTORS AND EFFECTS OF PRIVATE HEALTH SPENDING | Abstract similar documents |
| O. A. Zarubina, N. N. Sisigina | ||
| "... Уровень частных расходов на здравоохранение в современных развитых странах существенно различается ..." | ||
| Vol 9, No 2 (2016) | PHARMACOECONOMIC ANALYSIS OF VESOMNI (SOLIFENACIN AND CONTROLLED RELEASE TAMSULOSIN) TREATMENT OF STORAGE SYMPTOMS ASSOCIATED WITH BENIGN PROSTATIC HYPERPLASIA | Abstract similar documents |
| N. A. Avxentyev, M. Yu. Frolov | ||
| "... tamsulosin and solifenacin therapy, including 35,400 patients eligible for government reimbursement. Using ..." | ||
| Vol 9, No 3 (2016) | COPAYMENTS OF THE CITIZENS IN HEALTHCARE SYSTEM: INTERNATIONAL PRACTICE | Abstract similar documents |
| A. P. Tatarinov, D. V. Lukyantseva, L. S. Melnikova, V. V. Omelyanovskii | ||
| "... эффективного и справедливого финансирования здравоохранения, о которых и пойдет речь в данной статье. ..." | ||
| Vol 9, No 4 (2016) | PROPOSALS AND RECOMMENDATIONS FOR OPTIMIZATION OF THE PROGRAM OF STATE GUARANTEES FОR FREE MEDICAL CARE FOR RUSSIAN CITIZENS | Abstract similar documents |
| D. V. Fedyaev, D. V. Lukyantseva, V. I. Ignatyeva | ||
| "... документального обеспечения системы здравоохранения. Включение в нормативные документы механизмов конкретизации ..." | ||
| Vol 9, No 4 (2016) | REVIEW OF PRACTICE AND POSSIBLE DIRECTIONS OF CONCRETIZATION THE PROGRAM OF STATE GUARANTEES FОR FREE MEDICAL CARE FOR RUSSIAN CITIZENS | Abstract similar documents |
| D. V. Fedyaev, L. S. Melnikova, V. I. Ignatyeva | ||
| Vol 10, No 3 (2017) | Provision of free medical care in Russia and elsewhere: review of regulatory and legal aspects | Abstract similar documents |
| A. N. Daikhes, D. V. Fedyaev | ||
| "... бесплатной медицинской помощи. Рассмотрены рекомендации ООН, Всемирной организации здравоохранения и ..." | ||
| Vol 8, No 4 (2015) | HEALTHCARE SPENDING EFFICIENCY IN RUSSIAN REGIONS | Abstract similar documents |
| N. A. Avxentyev, V. M. Baydin, O. A. Zarubina, N. N. Sisigina, S. A. Kulkova | ||
| "... Соотношение ожидаемой продолжительности жизни и подушевых расходов на здравоохранение в России ..." | ||
| Vol 12, No 3 (2019) | Regulatory and legal status of clinical guidelines and their role in the quality control of medical care in countries of the European Union, North America and Asia | Abstract similar documents |
| V. K. Fedyaeva , U. N. Dmitrieva , N. I. Juravleva , N. I. Juravlev , M. Yu. Kovaleva , A. S. Korobkina , O. A. Sukhorukikh , A. A. Pashkina | ||
| "... здравоохранения на примере отобранных 12 стран Европы, Азии и Северной Америки с крупной экономикой и/или ..." | ||
| Vol 12, No 4 (2019) | Crucial areas of the economic analysis of public cancer care | Abstract similar documents |
| D. A. Andreev, K. I. Polyakova, A. A. Zavyalov, T. N. Ermolaeva, A. G. Fisun, A. D. Ermolaeva, V. A. Dubovtseva, T. E. Maksimova | ||
| "... внимание со стороны ученых-экономистов, врачей-организаторов здравоохранения, медицинских менеджеров. В ..." | ||
| Vol 7, No 1 (2014) | CLINICAL AND ECONOMIC ANALYSIS IN ASSESSMENT OF HEALTH CARE TECHNOLOGIES IN HEALTH CARE INSTITUTIONS | Abstract similar documents |
| I. B. Gaykovaya, A. T. Burbello, A. I. Ermakov, A. S. Fedorenko, T. V. Vavilova, M. V. Komok | ||
| Vol 7, No 2 (2014) | CLINICAL AND ECONOMIC EVALUATION OF IVABRADINE USE IN STABLE ANGINA IN TERMS OF REPUBLIC OF BELARUS HEALTH CARE SYSTEM | Abstract similar documents |
| I. N. Kozhanova, I. S. Romanova, L. N. Gavrilenko, A. V. Patseev, M. M. Sachek | ||
| "... заболеваниям, требующим значительных финансовых затрат со стороны системы здравоохранения и пациентов ..." | ||
| Vol 6, No 4 (2013) | Pharmacoeconomic study of nutrition support in the conditions of current health care system in Russia | Abstract similar documents |
| I. A. Metelkin, R. I. Yagudina | ||
| "... бюджета в целом и системы здравоохранения в частности. Независимо от тяжести состояния пациента ..." | ||
| Vol 8, No 2 (2015) | REVIEW OF THE INTERNATIONAL PRACTICE OF COST-SHARING MECHANISM IN NATIONAL HEALTH CARE SYSTEMS | Abstract similar documents |
| Natalia Nikolayevna Sisigina, Vitalii Vladimirovich Omel'yanovskii, Nikolay Alexandrovich Avxentyev | ||
| Vol 11, No 4 (2018) | “Near miss” in obstetrics: classification, evaluation, and significance for healthcare technology assessment | Abstract similar documents |
| I. K. Мamontova, T. V. Shevlyakovа, E. I. Petrova | ||
| "... аудита случаев «near miss» для оценки технологий здравоохранения, обсуждаются клинико-экономические ..." | ||
| Vol 12, No 3 (2019) | Пост-релиз Международной научно-практической конференции на тему: «Развитие оценки технологий здравоохранения в странах СНГ» | Abstract similar documents |
| article Editorial | ||
| Vol 7, No 3 (2014) | THE ANALYSIS OF METHODOLOGIC CHARACTERISTICS OF RESEARCHES ON SOCIAL AND ECONOMIC BURDEN OF DISEASES IN RUSSIA IN THE FRAMES OF DEVELOPMENT OF STANDARD COST OF ILLNESS METHODOLOGY FOR THE HEALTH TECHNOLOGY ASSESSMENT | Abstract similar documents |
| V. I. Ignatyeva, M. V. Avxentyeva | ||
| "... использования при оценке технологий здравоохранения. Материалы и методы. В результате анализа методических ..." | ||
| Vol 8, No 2 (2015) | PRINCIPLES OF IMPORT SUBSTITUTION REGARDING DRUGS | Abstract similar documents |
| Alana Viktorovna Dzaneva, Vitalii Vladimirovich Omel'yanovskii, Saniyat Aleksandrovna Kagermazova | ||
| "... ограничительных перечней на различных уровнях системы здравоохранения. В статье рассматривается методология ..." | ||
| Vol 10, No 1 (2017) | THE USE OF QALY AS AN INTEGRAL MEASURE OF EFFECTIVENESS IN THE EVALUATION OF MEDICAL TECHNOLOGIES | Abstract similar documents |
| N. Z. Musina, V. K. Fedyaeva | ||
| "... критерий эффективности при проведении оценки технологий здравоохранения. Его универсальность позволяет ..." | ||
| Vol 11, No 4 (2018) | Financial statistical reporting by medical organizations: shortcomings and areas of optimization | Abstract similar documents |
| M. L. Lazareva, I. V. Tyurina | ||
| "... , предоставляемой медицинскими организациями в сфере здравоохранения, а именно: дублирование и пересечение ..." | ||
| Vol 12, No 4 (2019) | Developing clinical guidelines and assessing the quality of medical care using the RAND/UCLA method | Abstract similar documents |
| O. O. Buzuverova, V. K. Fedyaeva, O. A. Sukhorukikh | ||
| "... здравоохранения. Предпосылкой к его созданию была необходимость в методе, который при принятии решения о ..." | ||
| Vol 10, No 1 (2017) | PERAMPANEL EFFECTIVENESS IN THE TREATMENT OF REFRACTERY PARTIAL ONSET EPILEPSY WITH OR WITHOUT SECONDARY GENERALIZATION: PHARMACOECONOMIC ANALYSIS FOR THE RUSSIAN FEDERATION HEALTH CARE SYSTEM | Abstract similar documents |
| N. K. Mazina, I. V. Sheshunov, P. V. Мazin, Yu. V. Kislitsin, E. M. Markova | ||
| "... уровень затрат при лечении перампанелом в условиях российского здравоохранения. Материалы и методы. Для ..." | ||
| Vol 11, No 3 (2018) | Determination of a willingness-to-pay threshold and decision-making in financing the healthcare technologies | Abstract similar documents |
| T. S. Teptsova, T. P. Bezdenezhnyh, V. K. Fedyaeva, N. Z Musina, G. R. Hachatryan, V. V. Tarasov | ||
| "... величины в рамках российской системы здравоохранения. Материалы и методы. ПГП рассчитывался методом оценки ..." | ||
| Vol 10, No 3 (2017) | Review of the current approaches to the assessment of the drug innovative potential worldwide | Abstract similar documents |
| N. Z. Musina, V. K. Fedyaeva, V. V. Omel’yanovskii, G. R. Khachatryan, K. V. Gerasimova, V. A. Lemeshko, K. P. Konchits | ||
| "... significance of a new medical product and make an educated decision on the reimbursement, cost and priority ..." | ||
| Vol 10, No 1 (2017) | PHARMACOECONOMIC ANALYSIS OF BRENTUXIMAB VEDOTIN THERAPY IN RELAPSED OR REFRACTORY CD30+ SYSTEMIC ANAPLASTIC LARGE CELL LYMPHOMA IN PATIENTS OVER 18 YEARS OF AGE: HEALTH BUDGET IMPACT ANALYSIS | Abstract similar documents |
| A. S. Kolbin, I. A. Vilum, М. A. Proskurin, Yu. E. Balykina | ||
| "... Цель – оценить расходы здравоохранения на применение брентуксимаба ведотина в терапии ..." | ||
| Vol 6, No 2 (2013) | COST-EFFECTIVENESS ANALYSIS OVER USE OF TYROSINE KINASE INHIBITORS (TASIGNA AND GLEEVEC) FOR TREATMENT OF CHRONIC MYELOID LEUKEMIA IN THE CHRONIC PHASE AS FIRST-LINE THERAPY FOR DE NOVO PATIENTS | Abstract similar documents |
| R. I. Yagudina, A. Yu. Kulikov, I. A. Komarov | ||
| Vol 6, No 3 (2013) | COST-UTILITY ANALYSIS OVER USE OF TYROSINE KINASE INHIBITORS (TASIGNA AND GLEEVEC) FOR TREATMENT OF CHRONIC MYELOID LEUKEMIA IN THE CHRONIC PHASE AS FIRST-LINE THERAPY FOR DE NOVO PATIENTS | Abstract similar documents |
| R. I. Yagudina, A. Yu. Kulikov, I. A. Komarov | ||
| Vol 5, No 3 (2012) | RATIONALE FOR THE SYSTEM OF INDICATORS, INTENDED FOR THE EVALUATION OF INVESTMENT EFFECTIVENESS IN THE FINANCING OF INVESTMENT PROJECTS IMPLEMENTED USING THE FUNDS OF THE POPULATION | Abstract similar documents |
| E. V. Litvinenko | ||
| "... и социальной сферы, здравоохранения. ..." | ||
| Vol 11, No 2 (2018) | Current practice of organizing and financing the departmental healthcare system for the military in developed countries: a review | Abstract similar documents |
| T. P. Bezdenezhnykh, D. V. Lukyantseva | ||
| "... Ведомственная медицина является организационной особенностью системы здравоохранения Российской ..." | ||
| Vol 12, No 4 (2019) | Evolution of healthcare provider payment mechanisms | Abstract similar documents |
| V. V. Omelyanovskiy, N. N. Sisigina, V. K. Fedyaeva, N. Z. Musina | ||
| "... здравоохранения, определяющий мотивы деятельности поставщиков услуг. На всем протяжении развития общественного ..." | ||
| Vol 5, No 1 (2012) | UN MILLENNIUM DEVELOPMENT GOALS INDICATORS ON PROBLEMS OF ACCESS TO ESSENTIAL MEDICINES AND ENHANCEMENT OF LOCAL PHARMACEUTICAL PRODUCER IN DEVELOPING COUNTRIES | Abstract similar documents |
| A. Y. Kulikov, A. G. Voskanyan | ||
| "... организации здравоохранения, направленные на реализацию прав человека на здоровье и развитие. ..." | ||
| Vol 7, No 1 (2014) | ABC END VEN ANALYSYS OF COSTS FOR MEDICINE SAND MEDICAL TREATMENT COSTS PATIENT | Abstract similar documents |
| M. A. Shapovalova, L. R. Koretskaya | ||
| "... здравоохранения Отделенческая больница на станции Астрахань-1 ОАО «РЖД» нами были проведены АВС- и VEN- анализы ..." | ||
| Vol 7, No 4 (2014) | APPLICATION OF MULTIPLE-CRITERIA ANALYSIS FOR OPTIMIZATION OF FINANCING OF RARE DISEASES | Abstract similar documents |
| V. V. Omelyanovskiy, V. K. Fedyaeva, O. Yu. Rebrova | ||
| "... , финансирование здравоохранения, управление здравоохранением, научная деятельность), в результате которого было ..." | ||
| Vol 5, No 1 (2012) | PHARMACOECONOMICS AS A NEW INSTRUMENT OF PHARMACEUTICAL MARKETING | Abstract similar documents |
| M. V. Protsenko, N. I. Koroleva | ||
| "... , принимающим решения в системе здравоохранения и «как» донести эту информацию в полном и неискаженном виде ..." | ||
| 1 - 50 of 101 Items | 1 2 3 > >> | |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
